Update Your Research Preferences To ensure that we continue to tailor our communications to your specific interests, please manage your research preferences using the form below. Trusted by labs worldwide Join top biotech, pharma, and academic researchers using Bruker Cellular Analysis to reclaim lab time, save precious samples, increase efficacy, and cut down therapeutic timelines […]
Update Your Research Preferences Read More »
Optofluidic chips and reagentsT Cell Profiling Kit Characterize T Cell Function and Link Phenotype to Genotype Download Product Sheet OVERVIEWUnlock Deeper Insights into T Cell Function with the T Cell Profiling Kit for the Beacon® Platform This kit enables you to: Analyze multiple functions simultaneously: Assess dynamic cytotoxicity, surface markers, and multiplexed cytokine secretion in
T Cell Profiling Kit Read More »
Optofluidic Chips and ReagentsCell Line Development Kit Compress your cell line development timeline Download Product Sheet OVERVIEWA Next Generation Solution on the Beacon® Platform that Compresses the Cell Line Development Timeline With the Cell Line Development kit for the Beacon platform, you can select productive, high-quality clones, significantly streamlining your clone selection process compared to
Cell Line Development Kit Read More »
Optofluidic Chips and ReagentsAntibody Discovery Kit Powering Your Success in Single B Cell Antibody Discovery Download Product Sheet OVERVIEWStreamline Monoclonal Antibody Discovery with Advanced Reagents and Chips for the Beacon Platform The Antibody Discovery kit for the Beacon® platform lets you screen plasma cells or memory B cells and find valuable monoclonal antibodies within a
Antibody Discovery Kit Read More »
Customer SpotlightAmgen on Antibody Discovery and Cell Line Development CUSTOMER QUOTE“In the long run, this technology will help us to solve complex problems that are too hard or expensive to solve with our current tools.” — Philip Tagari, Vice President of Therapeutic Discovery, Amgen TRANSFORMATIVE TECHNOLOGY As one of the early customers to have adopted
Amgen on Antibody Discovery and Cell Line Development Read More »
Customer SpotlightCatalent Biologics on Cell Line Development MEET CatalentGet “True” Productivity By incorporating the Beacon system into their process, Catalent reduced their timeline and generated better clones by having more clones screened and providing them with better initial estimates of “true” productivity prior to scaling up the cell lines for production. In Catalent’s Application Note,
Catalent Biologics on Cell Line Development Read More »
Customer SpotlightGenovac on Antibody Discovery MEET GenovacGoing Where Hybridoma Can’t In the recent webinar, Tackle Difficult Targets by Accessing Broad B Cell Diversity, Genovac demonstrated how the Opto™ Plasma B Discovery workflow can yield up to 10-times more hits than hybridoma campaigns against difficult membrane targets like GPCRs and other multi-pass transmembrane targets. The three
Genovac on Antibody Discovery Read More »
Customer SpotlightAbveris on Antibody Discovery MEET ABVERISRapid End-to-End Antibody Discovery Abveris is an antibody discovery partner with a focus on challenging therapeutic targets. They provide comprehensive gene-to-antibody discovery services by applying advanced immunization methods combined with B cell screening and hybridoma-based antibody discovery technologies. In order to reduce their timelines and discover antibodies against difficult
Abveris on Antibody Discovery Read More »
Customer SpotlightMedical College of Wisconsin on T Cell Characterization Medical College of WisconsinIdentifying the Biological Properties of Car T Cells That Favor Tumor Killing Using the Lighting™ Single Cell System Listen in on Dr. Anthony Zamora’s talk from CAR-TCR Summit 2021. Dr. Zamora covers topics, including: Identifying how modifications in CAR T cell manufacturing can
Medical College of Wisconsin on T Cell Characterization Read More »
Customer SpotlightMYCENAX: Developing the Next-Gen Cell Line Development Platform with [Bruker Cellular Analysis] MEET MYCENAXA leader in CMC development and GMP manufacturing in Taiwan Mycenax Biotech Inc., established in 2001, is a leading biopharmaceutical company in CMC development and GMP manufacturing in Taiwan. Their expertise includes cell line development, process development, formulation, analytical methods, GMP
